Twist Methylated UMI Adapters

Liquid biopsy technologies are rapidly transforming the landscape of early cancer detection and monitoring. By offering a minimally invasive approach, liquid biopsies enable the analysis of circulating biomarkers such as cfDNA(cell-freeDNA), which carry valuable information about cancer-associated genetic and epigenetic alterations. Among these biomarkers, DNA methylation changes stand out as a promising avenue for identifying and tracking various cancers with high specificity and sensitivity.

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Twist Methylated UMI Adapters

Related Resources

Capabilities of the New Twist NGS Methylation Detection System

Highly Sensitive Methylation Detection Using Enzymatic Methyl-seq and Twist Target Enrichment